Serological and Virological Evidence of Crimean-Congo Haemorrhagic Fever Virus Circulation in the Human Population of Borno State, Northeastern Nigeria

PLoS Negl Trop Dis. 2016 Dec 7;10(12):e0005126. doi: 10.1371/journal.pntd.0005126. eCollection 2016 Dec.

Abstract

Background: Despite several studies on the seroprevalence of antibodies against Crimean-Congo Haemorrhagic Fever virus (CCHFV) from humans and cattle in Nigeria, detailed investigation looking at IgG and IgM have not been reported. Additionally, there have been no confirmed cases of human CCHFV infection reported from Nigeria.

Principal findings: Samples from sera (n = 1189) collected from four Local Government Areas in Borno State (Askira/Uba, Damboa, Jere and Maiduguri) were assessed for the presence of IgG and IgM antibodies. The positivity rates for IgG and IgM were 10.6% and 3.5%, respectively. Additionally, sera from undiagnosed febrile patients (n = 380) were assessed by RT-PCR assay for the presence of CCHFV RNA. One positive sample was characterised by further by next generation sequencing (NGS) resulting in complete S, M and L segment sequences.

Conclusions: This article provides evidence for the continued exposure of the human population of Nigeria to CCHFV. The genomic analysis provides the first published evidence of a human case of CCHFV in Nigeria and its phylogenetic context.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / blood*
  • Cattle
  • Hemorrhagic Fever Virus, Crimean-Congo / classification
  • Hemorrhagic Fever Virus, Crimean-Congo / genetics
  • Hemorrhagic Fever Virus, Crimean-Congo / immunology
  • Hemorrhagic Fever Virus, Crimean-Congo / isolation & purification*
  • Hemorrhagic Fever, Crimean / blood
  • Hemorrhagic Fever, Crimean / epidemiology
  • Hemorrhagic Fever, Crimean / virology*
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin M / blood
  • Nigeria / epidemiology
  • Phylogeny
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Immunoglobulin M

Grants and funding

Work conducted at Public Health England was supported by Grant-In-Aid funding from the UK Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.